PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-18.51%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.97%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
4.88%
Maintaining or increasing dividends while NXPI cut them. John Neff might see a strong edge in shareholder returns.
-0.67%
Negative OCF growth while NXPI is at 11.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
75.57%
FCF growth above 1.5x NXPI's 19.85%. David Dodd would verify if the firm’s strategic investments yield superior returns.
61.04%
10Y revenue/share CAGR under 50% of NXPI's 153.91%. Michael Burry would suspect a lasting competitive disadvantage.
15.12%
5Y revenue/share CAGR under 50% of NXPI's 62.27%. Michael Burry would suspect a significant competitive gap or product weakness.
1.24%
3Y revenue/share CAGR under 50% of NXPI's 48.82%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
91.92%
10Y OCF/share CAGR under 50% of NXPI's 236.87%. Michael Burry would worry about a persistent underperformance in cash creation.
-5.86%
Negative 5Y OCF/share CAGR while NXPI is at 71.86%. Joel Greenblatt would question the firm’s operational model or cost structure.
-8.36%
Negative 3Y OCF/share CAGR while NXPI stands at 16.82%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
220.89%
Below 50% of NXPI's 596.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.14%
Below 50% of NXPI's 187.76%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-17.80%
Negative 3Y CAGR while NXPI is 145.94%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
87.00%
Below 50% of NXPI's 537.44%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
97.18%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
86.15%
3Y equity/share CAGR above 1.5x NXPI's 5.37%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
333.29%
Dividend/share CAGR of 333.29% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
68.41%
Below 50% of NXPI's 286.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
27.57%
Below 50% of NXPI's 160.31%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-9.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.33%
We show growth while NXPI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.24%
Asset growth above 1.5x NXPI's 1.49%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.60%
75-90% of NXPI's 1.92%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
5.05%
Debt growth far above NXPI's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.34%
Our R&D shrinks while NXPI invests at 8.32%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.10%
We cut SG&A while NXPI invests at 5.78%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.